<code id='92FD249035'></code><style id='92FD249035'></style>
    • <acronym id='92FD249035'></acronym>
      <center id='92FD249035'><center id='92FD249035'><tfoot id='92FD249035'></tfoot></center><abbr id='92FD249035'><dir id='92FD249035'><tfoot id='92FD249035'></tfoot><noframes id='92FD249035'>

    • <optgroup id='92FD249035'><strike id='92FD249035'><sup id='92FD249035'></sup></strike><code id='92FD249035'></code></optgroup>
        1. <b id='92FD249035'><label id='92FD249035'><select id='92FD249035'><dt id='92FD249035'><span id='92FD249035'></span></dt></select></label></b><u id='92FD249035'></u>
          <i id='92FD249035'><strike id='92FD249035'><tt id='92FD249035'><pre id='92FD249035'></pre></tt></strike></i>

          Home / entertainment / comprehensive

          comprehensive


          comprehensive

          author:hotspot    Page View:73
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In